Status:
UNKNOWN
Evolution of Muscle Function, Breathlessness and Quality of Life Following Intra or Extra-Abdominal Sepsis in ICU Patients
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Conditions:
Sepsis
Septic Shock
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Sepsis is organ dysfunction secondary to an inappropriate host response to infection. In the most severe cases, circulatory failure necessitating the introduction of vasopressor therapy is called sept...
Eligibility Criteria
Inclusion
- Patient over 18 years of age,
- Patient admitted to a critical care unit at Paris Saint-Joseph Hospital,
- Sepsis or septic shock (defined by the international consensus conference "sepsis-3"),
- Sepsis/septic shock less than 72 hours old,
- Patient affiliated to a health insurance scheme,
- French-speaking patient,
- Patient or relative who has given free, informed and express consent.
Exclusion
- History of documented chronic muscular disease, whatever the cause (neuromuscular damage, abdominal or diaphragmatic hernia, muscular damage of inflammatory origin, myopathies, etc.),
- Moribund patients,
- Patient already included in a type 1 interventional research protocol (RIPH1),
- Patient under guardianship,
- Patient deprived of liberty,
- Patient under court protection,
- Pregnant patient.
Key Trial Info
Start Date :
July 28 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT06010186
Start Date
July 28 2023
End Date
December 31 2025
Last Update
August 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Paris Saint-Joseph
Paris, France, 75014